All Stories

  1. The diagnosis, management and prevention of intertrigo in adults: a review
  2. Atypical Ulcers: Diagnosis and Management
  3. Itch in Chronic Wounds: Pathophysiology, Impact, and Management
  4. Biomodulation induced by fluorescent light energy versus standard of care in venous leg ulcers: a retrospective study
  5. Potential role of serum amyloid A in hidradenitis suppurativa
  6. Breast surgeons dealing with Munchausen syndrome: A self‐induced necrotic phlegmon of the breast treated with surgery, negative pressure and epidermal fractional skin grafting
  7. Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel
  8. Tuscan consensus on the use of UVBnb phototherapy in the treatment of psoriasis
  9. Is it really just a small world?
  10. Sex‐related differences of clinical features in hidradenitis suppurativa: analysis of an Italian‐based cohort
  11. Necrotoxic spider bite: a successful noninvasive wound management
  12. Risankizumab for the treatment of moderate to severe psoriasis
  13. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial
  14. Enhancing daily practice through knowledge sharing
  15. Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group
  16. Cell salvage in acute and chronic wounds: a potential treatment strategy. Experimental data and early clinical results
  17. Acne fulminans associated with lymecycline intake: a case report
  18. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directe
  19. Elderly psoriatic patients under biological therapies: an Italian experience
  20. Catching the vulnologists around the globe
  21. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries
  22. Long-Term Outcome of Adalimumab in a Young Girl with Hidradenitis Suppurativa
  23. The Hidradenitis Suppurativa (HS) “Multidisciplinary Unit”: a rationale and practical proposal for an organised clinical approach
  24. Optimising collaboration in science and clinical practice
  25. Scanning the Immunopathogenesis of Psoriasis
  26. Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients
  27. Determination of salivary α-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test
  28. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis
  29. Sensors and Biosensors for C-Reactive Protein, Temperature and pH, and Their Applications for Monitoring Wound Healing: A Review
  30. EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis
  31. A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
  32. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus
  33. Biomarkers—an unmet need in wound care
  34. Evaluation of osteopontin expression in chronic wounds: a potential prognostic and therapeutic biomarker
  35. Introducing the new WUWHS executive and editorial board
  36. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
  37. Temperature and pH sensors based on graphenic materials
  38. Association between HCV infection and cutaneous-mucosal lichen planus: an update
  39. TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
  40. Primary cutaneous diffuse large B-cell lymphoma presenting as chronic non-healing ulcer
  41. Temperature- and pH-sensitive wearable materials for monitoring foot ulcers
  42. Optimizing acitretin use in patients with plaque psoriasis
  43. Contact dermatitis in patients with chronic leg ulcers: a common and neglected problem: a review 2000–2015
  44. No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents
  45. Epidermal skin grafting in vitiligo: a pilot study
  46. Use of advanced technologies across the wound care spectrum: prologue
  47. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis
  48. The world of wounds comes together
  49. Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity
  50. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015)
  51. Recommendations for the management of biofilm: a consensus document
  52. A revolutionary therapeutic approach for psoriasis: bispecific biological agents
  53. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing
  54. A D-optimal design to model the performances of dressings and devices for negative pressure wound therapy
  55. Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
  56. What's new: Management of venous leg ulcers
  57. What's new: Management of venous leg ulcers
  58. Erratum: Erratum: Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  59. The use of a collagen matrix in hard-to-heal venous leg ulcers
  60. Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  61. Hidradenitis Suppurativa and Wound Management
  62. Biologic drugs in wound management
  63. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers – a randomized pilot study
  64. Fractional epidermal skin grafting
  65. The role of biomedical sensors in wound healing
  66. Cryoglobulinemia
  67. Quantitative Evaluation of Maceration in Venous Leg Ulcers by Transepidermal Water Loss (TEWL) Measurement
  68. Chronic wound management and research
  69. Physical Therapy in Wound Healing, Edema, and Urinary Incontinence
  70. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  71. Introduction
  72. Cutaneous ulcers associated with hydroxyurea therapy
  73. Dear readers
  74. Cutaneous foetal injuries related to amniocentesis
  75. Improvement of Periulcer Skin Condition in Venous Leg Ulcer Patients
  76. SWAN-iCare: A smart wearable and autonomous negative pressure device for wound monitoring and therapy
  77. Use of diagnostics in wound management
  78. Efficacy of Adalimumab for the Treatment of Refractory Paediatric Acrodermatitis Continua of Hallopeau
  79. Measurements in Wound Healing
  80. A temperature sensor based on a MWCNT/SEBS nanocomposite
  81. Skin and Vascular Assessments
  82. Skin temperature monitoring by a wireless sensor
  83. Classification of Wounds at Risk and Their Antimicrobial Treatment with Polihexanide: A Practice-Oriented Expert Recommendation
  84. Evaluation of the Efficacy and Tolerability of a Solution Containing Propyl Betaine and Polihexanide for Wound Irrigation
  85. Dilemmas in measuring and using pressure ulcer prevalence and incidence: an international consensus
  86. Ibuprofen slow-release foam dressing reduces wound pain in painful exuding wounds: Preliminary findings from an international real-life study
  87. Efficacy and tolerance of a hydrocolloid dressing containing hyaluronic acid for the treatment of leg ulcers of venous or mixed origin
  88. Clinical significance of cutaneous proteoglycan (mucin) infiltration in patients with mitral valve prolapse
  89. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: Experimental and clinical evidence  ||FREE PAPER||
  90. Use of Nanotechnology-Designed Footsock in the Management of Preulcerative Conditions in the Diabetic Foot: Results of a Single, Blind Randomized Study
  91. Dressing‐related pain in patients with chronic wounds: an international patient perspective
  92. Hip fracture and pressure ulcers – the Pan-European Pressure Ulcer Study – intrinsic and extrinsic risk factors
  93. Hydroxyurea-Induced Leg Ulcers Treated With a Protease-Modulating Matrix
  94. Wound Assessment by 3-Dimensional Laser Scanning
  95. Improvement of Idiopathic Pyoderma Gangrenosum During Treatment With Anti-Tumor Necrosis Factor Alfa Monoclonal Antibody
  96. OASIS�wound matrix versus Hyaloskin�in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology
  97. Prevention and management of pressure ulcers
  98. Microcirculation - a Blarney Stone to Wound Healing
  99. The effect of amelogenins (Xelma™) on hard-to-heal venous leg ulcers
  100. Cutaneous Tissue Engineering and Lower Extremity Wounds (Part 2)
  101. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial
  102. Wound bed preparation and a brief history of TIME
  103. Semiquantitative Analysis of the Histopathological Features of the Neuropathic Foot Ulcer: Effects of pressure relief
  104. Angiogenesis and nerve regeneration in a model of human skin equivalent transplant
  105. Wound bed preparation: a systematic approach to wound management
  106. Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot
  107. Hardness of Plantar Skin in Diabetic Neuropathic Feet
  108. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis
  109. The effect of topical nitroglycerin on transcutaneous oxygen